{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T21:38:25Z","timestamp":1791322705461,"version":"4.3.1"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"name":"aHUS alliance"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1186\/s13023-016-0537-5","type":"journal-article","created":{"date-parts":[[2016,11,21]],"date-time":"2016-11-21T13:04:07Z","timestamp":1479733447000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["An innovative and collaborative partnership between patients with rare disease and industry-supported registries: the Global aHUS Registry"],"prefix":"10.1186","volume":"11","author":[{"name":"on behalf of the aHUS Registry SAB","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Len","family":"Woodward","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sally","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johan Vande","family":"Walle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joran","family":"Beck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"Gasteyger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"Licht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gema","family":"Ariceta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,11,21]]},"reference":[{"issue":"1","key":"537_CR1","doi-asserted-by":"crossref","first-page":"e008928","DOI":"10.1136\/bmjopen-2015-008928","volume":"6","author":"S Parsons","year":"2016","unstructured":"Parsons S, Starling B, Mullan-Jensen C, Tham SG, Warner K, Wever K. What do pharmaceutical industry professionals in Europe believe about involving patients and the public in research and development of medicines? A qualitative interview study. BMJ Open. 2016;6(1):e008928.","journal-title":"BMJ Open"},{"issue":"2","key":"537_CR2","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1038\/gim.0b013e3182310ba0","volume":"14","author":"DC Landy","year":"2012","unstructured":"Landy DC, Brinich MA, Colten ME, Horn EJ, Terry SF, Sharp RR. How disease advocacy organizations participate in clinical research: a survey of genetic organizations. Genet Med. 2012;14(2):223\u20138.","journal-title":"Genet Med"},{"key":"537_CR3","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s13023-016-0382-6","volume":"11","author":"D Pinto","year":"2016","unstructured":"Pinto D, Martin D, Chenhall R. The involvement of patient organisations in rare disease research: a mixed methods study in Australia. Orphanet J Rare Dis. 2016;11:2.","journal-title":"Orphanet J. Rare Dis."},{"key":"537_CR4","volume-title":"Engaging Patients in Information Sharing and Data Collection: The Role of Patient-Powered Registries and Research Networks","author":"TA Workman","year":"2013","unstructured":"Workman TA. Engaging Patients in Information Sharing and Data Collection: The Role of Patient-Powered Registries and Research Networks. Rockville (MD): AHRQ Methods for Effective Health Care; 2013."},{"key":"537_CR5","unstructured":"Gliklich RE, Dreyer NA, Leavy MA. (eds). Registries for Evaluating Patient Outcomes: A User\u2019s Guide. Third edition. (Prepared by the Outcome DEcIDE Center [Outcome Sciences, Inc., a Quintiles company] under Contract No. 290 2005 00351 TO7). AHRQ Publication No. 13(14)-EHC111. Rockville, MD: Agency for Healthcare Research and Quality. 2014. http:\/\/www.effectivehealthcare.ahrq.gov\/registries-guide-3.cfm . Accessed Nov 2016."},{"key":"537_CR6","volume-title":"2013 report on the state of the art of rare disease activities in Europe. Part I: overview of rare disease activities in Europe","author":"S Ayme","year":"2013","unstructured":"Ayme S, Rodwell C. 2013 report on the state of the art of rare disease activities in Europe. Part I: overview of rare disease activities in Europe. Paris: European Union Committee of Experts on Rare Diseases; 2013."},{"key":"537_CR7","unstructured":"EUCERD\/EMA Workshop Report: Towards a public-private partnership for registries in the field of rare diseases (4 October 2011). http:\/\/www.eucerd.eu\/?post_type=document&p=1234 . Accessed Nov 2016."},{"issue":"2","key":"537_CR8","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1038\/gim.2015.42","volume":"18","author":"BK Potter","year":"2016","unstructured":"Potter BK, Khangura SD, Tingley K, Chakraborty P, Little J. Translating rare-disease therapies into improved care for patients and families: what are the right outcomes, designs, and engagement approaches in health-systems research? Genet Med. 2016;18(2):117\u201323.","journal-title":"Genet Med"},{"issue":"5","key":"537_CR9","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.nefro.2015.07.005","volume":"35","author":"JM Campistol","year":"2015","unstructured":"Campistol JM, Arias M, Ariceta G, Blasco M, Espinosa L, Espinosa M, et al. An update for atypical haemolytic uraemic syndrome: Diagnosis and treatment. A consensus document. Nefrologia. 2015;35(5):421\u201347.","journal-title":"Nefrologia"},{"issue":"2","key":"537_CR10","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s00467-015-3076-8","volume":"31","author":"C Loirat","year":"2016","unstructured":"Loirat C, Fakhouri F, Ariceta G, Besbas N, Bitzan M, Bjerre A, et al. An international consensus approach to the management of atypical hemolytic uremic syndrome in children. Pediatr Nephrol. 2016;31(2):15\u201339.","journal-title":"Pediatr Nephrol"},{"issue":"4","key":"537_CR11","doi-asserted-by":"crossref","first-page":"554","DOI":"10.2215\/CJN.04760512","volume":"8","author":"V Fremeaux-Bacchi","year":"2013","unstructured":"Fremeaux-Bacchi V, Fakhouri F, Garnier A, Bienaime F, Dragon-Durey MA, Ngo S, et al. Genetics and outcome of atypical hemolytic uremic syndrome: a nationwide French series comparing children and adults. Clin J Am Soc Nephrol. 2013;8(4):554\u201362.","journal-title":"Clin. J. Am. Soc. Nephrol"},{"issue":"10","key":"537_CR12","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.2215\/CJN.02210310","volume":"5","author":"M Noris","year":"2010","unstructured":"Noris M, Caprioli J, Bresin E, Mossali C, Pianetti G, Gamba S, et al. Relative role of genetic complement abnormalities in sporadic and familial aHUS and their impact on clinical phenotype. Clin J Am Soc Nephrol. 2010;5(10):1844\u201359.","journal-title":"Clin. J. Am. Soc. Nephrol."},{"issue":"7","key":"537_CR13","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1056\/NEJMra1312353","volume":"371","author":"JN George","year":"2014","unstructured":"George JN, Nester CM. Syndromes of thrombotic microangiopathy. N Engl J Med. 2014;371(7):654\u201366.","journal-title":"N Engl J Med"},{"issue":"23","key":"537_CR14","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1056\/NEJMoa1208981","volume":"368","author":"CM Legendre","year":"2013","unstructured":"Legendre CM, Licht C, Muus P, Greenbaum LA, Babu S, Bedrosian C, et al. Terminal complement inhibitor eculizumab in atypical hemolytic-uremic syndrome. N Engl J Med. 2013;368(23):2169\u201381.","journal-title":"N Engl J Med"},{"issue":"3","key":"537_CR15","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/j.kint.2015.11.026","volume":"89","author":"LA Greenbaum","year":"2016","unstructured":"Greenbaum LA, Fila M, Ardissino G, Al-Akash SI, Evans J, Henning P, et al. Eculizumab is a safe and effective treatment in pediatric patients with atypical hemolytic uremic syndrome. Kidney Int. 2016;89(3):701\u201311.","journal-title":"Kidney Int"},{"issue":"1","key":"537_CR16","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1053\/j.ajkd.2015.12.034","volume":"68","author":"F Fakhouri","year":"2016","unstructured":"Fakhouri F, Hourmant M, Campistol JM, Cataland SR, Espinosa M, Gaber AO, et al. Terminal Complement Inhibitor Eculizumab in Adult Patients With Atypical Hemolytic Uremic Syndrome: A Single-Arm, Open-Label Trial. Am J Kidney Dis. 2016;68(1):84\u201393.","journal-title":"Am. J. Kidney Dis."},{"key":"537_CR17","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1186\/s12882-015-0195-1","volume":"16","author":"C Licht","year":"2015","unstructured":"Licht C, Ardissino G, Ariceta G, Cohen D, Cole A, Gasteyger C, et al. The global aHUS registry: methodology and initial patient characteristics. BMC Nephrol. 2015;16:207.","journal-title":"BMC Nephrol"},{"key":"537_CR18","unstructured":"aHUS Global Poll 2014. https:\/\/www.rareconnect.org\/en\/community\/atypical-hemolytic-uremic-syn\/article\/ahus-global-poll-2014-a-commentary-on-the-data . Accessed Nov 2016."},{"key":"537_CR19","unstructured":"aHUS Global Poll 2016. http:\/\/www.ahusallianceaction.org\/wp-content\/uploads\/2016\/05\/RR2016.pdf . Accessed Nov 2016."},{"issue":"Suppl 3","key":"537_CR20","doi-asserted-by":"crossref","first-page":"S788","DOI":"10.1007\/s11606-014-2895-9","volume":"29","author":"LP Forsythe","year":"2014","unstructured":"Forsythe LP, Szydlowski V, Murad MH, Ip S, Wang Z, Elraiyah TA, et al. A systematic review of approaches for engaging patients for research on rare diseases. J Gen Intern Med. 2014;29 Suppl 3:S788\u2013800.","journal-title":"J Gen Intern Med"},{"issue":"1","key":"537_CR21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-2796.2006.01666.x","volume":"260","author":"M Wastfelt","year":"2006","unstructured":"Wastfelt M, Fadeel B, Henter JI. A journey of hope: lessons learned from studies on rare diseases and orphan drugs. J Intern Med. 2006;260(1):1\u201310.","journal-title":"J Intern Med"},{"issue":"6","key":"537_CR22","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1159\/000355930","volume":"16","author":"A Montserrat Moliner","year":"2013","unstructured":"Montserrat Moliner A, Waligora J. The European union policy in the field of rare diseases. Public Health Genomics. 2013;16(6):268\u201377.","journal-title":"Public Health Genomics"},{"issue":"2","key":"537_CR23","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S0168-8510(01)00214-7","volume":"61","author":"J Boote","year":"2002","unstructured":"Boote J, Telford R, Cooper C. Consumer involvement in health research: a review and research agenda. Health Policy. 2002;61(2):213\u201336.","journal-title":"Health Policy"},{"key":"537_CR24","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1186\/1472-6963-14-89","volume":"14","author":"JP Domecq","year":"2014","unstructured":"Domecq JP, Prutsky G, Elraiyah T, Wang Z, Nabhan M, Shippee N, et al. Patient engagement in research: a systematic review. BMC Health Serv Res. 2014;14:89.","journal-title":"BMC Health Serv Res"},{"issue":"2","key":"537_CR25","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1111\/j.1369-7625.2009.00549.x","volume":"13","author":"TA Abma","year":"2010","unstructured":"Abma TA, Broerse JE. Patient participation as dialogue: setting research agendas. Health Expect. 2010;13(2):160\u201373.","journal-title":"Health Expect"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-016-0537-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,25]],"date-time":"2017-06-25T04:05:36Z","timestamp":1498363536000},"score":1,"resource":{"primary":{"URL":"http:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-016-0537-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11,21]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["537"],"URL":"https:\/\/doi.org\/10.1186\/s13023-016-0537-5","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,11,21]]},"article-number":"154"}}